{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bioavailability", "Drug absorption", "Formulation approaches", "Lipid-based micelles", "Lipid-based nanoparticles", "Lipids", "Lipophilic drugs", "Liposomes", "Self-emulsifying drug delivery systems", "Solubility", "Stability"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38053738", "DateRevised": {"Year": "2023", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "10"}], "Language": ["eng"], "ELocationID": ["101870", "10.1016/j.jsps.2023.101870"], "Journal": {"ISSN": "1319-0164", "JournalIssue": {"Volume": "31", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society", "ISOAbbreviation": "Saudi Pharm J"}, "ArticleTitle": "Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.", "Pagination": {"StartPage": "101870", "MedlinePgn": "101870"}, "Abstract": {"AbstractText": ["This review aims to provide a thorough examination of the benefits, challenges, and advancements in utilizing lipids for more effective drug delivery, ultimately contributing to the development of innovative approaches in pharmaceutical science. Lipophilic drugs, characterized by low aqueous solubility, present a formidable challenge in achieving effective delivery and absorption within the human body. To address this issue, one promising approach involves harnessing the potential of lipids. Lipids, in their diverse forms, serve as carriers, leveraging their unique capacity to enhance solubility, stability, and absorption of these challenging drugs. By facilitating improved intestinal solubility and selective lymphatic absorption of porously permeable drugs, lipids offer an array of possibilities for drug delivery. This versatile characteristic not only bolsters the pharmacological efficacy of drugs with low bioavailability but also contributes to enhanced therapeutic performance, ultimately reducing the required dose size and associated costs. This comprehensive review delves into the strategic formulation approaches that employ lipids as carriers to ameliorate drug solubility and bioavailability. Emphasis is placed on the critical considerations of lipid type, composition, and processing techniques when designing lipid-based formulations. This review meticulously examines the multifaceted challenges that come hand in hand with lipid-based formulations for lipophilic drugs, offering an insightful perspective on future trends. Regulatory considerations and the broad spectrum of potential applications are also thoughtfully discussed. In summary, this review presents a valuable repository of insights into the effective utilization of lipids as carriers, all aimed at elevating the bioavailability of lipophilic drugs."], "CopyrightInformation": "\u00a9 2023 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Banasthali Vidyapith, Vanasthali Road, Aliyabad, Rajasthan 304022, India."}, {"Identifier": [], "Affiliation": "Gurugram Global College of Pharmacy, Haily Mandi Rd, Farukh Nagar, Haryana 122506, India."}], "LastName": "Preeti"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Banasthali Vidyapith, Vanasthali Road, Aliyabad, Rajasthan 304022, India."}], "LastName": "Sambhakar", "ForeName": "Sharda", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Maharishi Markandeswar Deemed to be University, Mullana, Ambala, Haryana 133203, India."}], "LastName": "Saharan", "ForeName": "Renu", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Panipat Institute of Engineering & Technology, Department of Pharmacy, GT Road, Samalkha, Panipat 132102, Haryana, India."}], "LastName": "Narwal", "ForeName": "Sonia", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gurugram Global College of Pharmacy, Haily Mandi Rd, Farukh Nagar, Haryana 122506, India."}], "LastName": "Malik", "ForeName": "Rohit", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIMT College of Pharmacy, Knowledge Park - 1, Greater Noida, District - Gautam Buddh Nagar, UP 201310, India."}], "LastName": "Gahlot", "ForeName": "Vinod", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Institute, National Center for Research, P.O. Box: 2424, Khartoum 11111, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Jazan, Saudi Arabia."}], "LastName": "Najmi", "ForeName": "Asim", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Jazan, Saudi Arabia."}], "LastName": "Zoghebi", "ForeName": "Khalid", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cinical Pharmacy, College of Pharmacy, Jazan University, P.O. Box 114, Jazan, Saudi Arabia."}], "LastName": "Halawi", "ForeName": "Maryam A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Jazan, Saudi Arabia."}], "LastName": "Albratty", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia."}, {"Identifier": [], "Affiliation": "School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Center for Global health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India."}], "LastName": "Mohan", "ForeName": "Syam", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi Pharm J", "NlmUniqueID": "9705695", "ISSNLinking": "1319-0164"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agrawal S., Giri T.K., Tripathi D.K., Ajazuddin A.A. A review on novel therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based Self Micro Emulsifying Drug Delivery System: a novel approach. Am. J. Drug Discov. Dev. 2012;2:143\u2013183. doi: 10.3923/ajdd.2012.143.183.", "ArticleIdList": ["10.3923/ajdd.2012.143.183"]}, {"Citation": "Akula S., Gurram A.K., Devireddy S.R. Self-microemulsifying drug delivery systems: an attractive strategy for enhanced therapeutic profile. Int. Scholarly Res. Notices. 2014;2014:1\u201311. doi: 10.1155/2014/964051.", "ArticleIdList": ["10.1155/2014/964051", "PMC4897095", "27382619"]}, {"Citation": "Alavi M., Nokhodchi A. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: recent advances and challenges. Drug Discov. Today. 2022;27:576\u2013584. doi: 10.1016/j.drudis.2021.10.007.", "ArticleIdList": ["10.1016/j.drudis.2021.10.007", "34688912"]}, {"Citation": "Anderson B.D., Marra M.T. Chemical and related factors controlling lipid solubility. Bull. Technique-Gattefoss\u00e9 Report. 1999;92:11\u201319."}, {"Citation": "Steven, M.A., Xinyao, D., 2023. Lipids and lipid nanoparticle formulations for delivery of nucleic acids. Canaada patent CA3003055C. AUG. 1st. https://patents.google.com/patent/CA3003055C/en?q."}, {"Citation": "Aoyagi N., Ogata H., Kaniwa N., Ejima A. Effect of food on the bioavailability of griseofulvin from Microsize and Peg ultramicrosize (Gris-PEGR) plain tablets. J. Pharmacobiodyn. 1982;5:120\u2013124. doi: 10.1248/bpb1978.5.120.", "ArticleIdList": ["10.1248/bpb1978.5.120", "7097474"]}, {"Citation": "Ari\u00ebn A., Goigoux C., Baquey C., Dupuy B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci. 1993;53:1279\u20131290. doi: 10.1016/0024-3205(93)90573-l.", "ArticleIdList": ["10.1016/0024-3205(93)90573-l", "8412488"]}, {"Citation": "Ari\u00ebn A., Henry-Toulm\u00e9 N., Dupuy B. Calcitonin-loaded liposomes: Stability under acidic conditions and bile salts-induced disruption resulting in calcitonin-phospholipid complex formation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1994;1193:93\u2013100. doi: 10.1016/0005-2736(94)90337-9.", "ArticleIdList": ["10.1016/0005-2736(94)90337-9", "8038199"]}, {"Citation": "Arya M., Bott S.R., Shergill I.S., Ahmed H.U., Williamson M., Patel H.R. The metastatic cascade in prostate cancer. Surg. Oncol. 2006;15:117\u2013128. doi: 10.1016/j.suronc.2006.10.002.", "ArticleIdList": ["10.1016/j.suronc.2006.10.002", "17150354"]}, {"Citation": "Aungst B.J. Cheminform abstract: Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. ChemInform. 2010;24 doi: 10.1002/chin.199351337.", "ArticleIdList": ["10.1002/chin.199351337", "8254497"]}, {"Citation": "Bach AiC, Babayan V.K. Medium-chain triglycerides: an update. Am. J. Clin. Nutr. 1982;36(5):950\u2013962.", "ArticleIdList": ["6814231"]}, {"Citation": "Banakar U.V. Wiley; Hoboken, NJ: 2022. Pharmaceutical dissolution testing, bioavailability, and bioequivalence: Science, applications, and beyond."}, {"Citation": "Benet L.Z. The role of BCS (biopharmaceutics classification system) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in drug development. J. Pharm. Sci. 2013;102:34\u201342. doi: 10.1002/jps.23359.", "ArticleIdList": ["10.1002/jps.23359", "PMC3684558", "23147500"]}, {"Citation": "Benet L., Cummins C., Wu C. Transporter-enzyme interactions: Implications for predicting drug-drug interactions from in vitro data. Curr. Drug Metab. 2003;4:393\u2013398. doi: 10.2174/1389200033489389.", "ArticleIdList": ["10.2174/1389200033489389", "14529371"]}, {"Citation": "Benet L.Z., Cummins C.L., Wu C.Y. Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int. J. Pharm. 2004;277:3\u20139. doi: 10.1016/j.ijpharm.2002.12.002.", "ArticleIdList": ["10.1016/j.ijpharm.2002.12.002", "15158963"]}, {"Citation": "Bergstedt S.E., Hayashi H., Kritchevsky D., Tso P. A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine. American Journal of Physiology-Gastrointestinal and Liver. Physiology. 1990;259 doi: 10.1152/ajpgi.1990.259.3.g386.", "ArticleIdList": ["10.1152/ajpgi.1990.259.3.g386", "2205112"]}, {"Citation": "Bernb\u00e4ck S., Bl\u00e4ckberg L., Hernell O. Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1989;1001:286\u2013293. doi: 10.1016/0005-2760(89)90113-6.", "ArticleIdList": ["10.1016/0005-2760(89)90113-6", "2917153"]}, {"Citation": "Bhalani, V.T., Patel, S., inventors; Sidmak Laboratories Inc., assignee, 1999. Pharmaceutical compositions for cyclosporines. United States Patent US 5858401A. 1999 Jan 12."}, {"Citation": "Bootz A., Vogel V., Schubert D., Kreuter J. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 2004;57:369\u2013375. doi: 10.1016/s0939-6411(03)00193-0.", "ArticleIdList": ["10.1016/s0939-6411(03)00193-0", "15018998"]}, {"Citation": "Borgstr\u00f6m B. Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat. Gastroenterology. 1980;78:954\u2013962. doi: 10.1016/0016-5085(80)90777-5.", "ArticleIdList": ["10.1016/0016-5085(80)90777-5", "7380202"]}, {"Citation": "Brog\u00e5rd M., Troedsson E., Thuresson K., Ljusberg-Wahren H. A new standardized lipolysis approach for characterization of emulsions and dispersions. J. Colloid Interface Sci. 2007;308:500\u2013507. doi: 10.1016/j.jcis.2006.12.015.", "ArticleIdList": ["10.1016/j.jcis.2006.12.015", "17289070"]}, {"Citation": "Bucher, C., Ditzinger, G., Dubois, E., Marchaud, D., inventors; Basilea Pharmaceutica AG, assignee, 2013. Antifungal composition. United States Patent US 8536208B2. 2013 Sept 17."}, {"Citation": "Cao Y., Marra M., Anderson B.D. Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. J. Pharm. Sci. 2004;93:2768\u20132779. doi: 10.1002/jps.20126.", "ArticleIdList": ["10.1002/jps.20126", "15389678"]}, {"Citation": "Carey M.C. Small dm, bliss cm. Lipid digestion and absorption. Annu. Rev. Physiol. 1983;45:651\u2013677.", "ArticleIdList": ["6342528"]}, {"Citation": "Carey M.C., Small D.M., Bliss C.M. Lipid digestion and absorption. Annu. Rev. Physiol. 1983;45(1):651\u2013677.", "ArticleIdList": ["6342528"]}, {"Citation": "Carlton C.E., Ferreira P.J. In situ tem nanoindentation of nanoparticles. Micron. 2012;43:1134\u20131139. doi: 10.1016/j.micron.2012.03.002.", "ArticleIdList": ["10.1016/j.micron.2012.03.002", "22484052"]}, {"Citation": "Cense H.A., van Eijck C.H.J., Tilanus H.W. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract. Res. Clin. Gastroenterol. 2006;20:893\u2013906. doi: 10.1016/j.bpg.2006.03.010.", "ArticleIdList": ["10.1016/j.bpg.2006.03.010", "16997168"]}, {"Citation": "\u010cerpnjak K., Pobirk A.Z., Vre\u010der F., Ga\u0161perlin M. Tablets and minitablets prepared from spray-dried smedds containing naproxen. Int. J. Pharm. 2015;495:336\u2013346. doi: 10.1016/j.ijpharm.2015.08.099.", "ArticleIdList": ["10.1016/j.ijpharm.2015.08.099", "26341323"]}, {"Citation": "Chakraborty S., Shukla D., Mishra B., Singh S. Lipid \u2013 an emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm. 2009;73:1\u201315. doi: 10.1016/j.ejpb.2009.06.001.", "ArticleIdList": ["10.1016/j.ejpb.2009.06.001", "19505572"]}, {"Citation": "Charman W.N., Porter C.J.H. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 1996;19:149\u2013169. doi: 10.1016/0169-409x(95)00105-g.", "ArticleIdList": ["10.1016/0169-409x(95)00105-g"]}, {"Citation": "Charman W.N., Rogge M.C., Boddy A.W., Berger B.M. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 1993;33:381\u2013386. doi: 10.1002/j.1552-4604.1993.tb04673.x.", "ArticleIdList": ["10.1002/j.1552-4604.1993.tb04673.x", "8473554"]}, {"Citation": "Chatterjee B., Hamed Almurisi S., Ahmed Mahdi Dukhan A., Mandal U.K., Sengupta P. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Delivery. 2016;23:3639\u20133652. doi: 10.1080/10717544.2016.1214990.", "ArticleIdList": ["10.1080/10717544.2016.1214990", "27685505"]}, {"Citation": "Chavan R.B., Modi S.R., Bansal A.K. Role of solid carriers in pharmaceutical performance of solid supersaturable sedds of celecoxib. Int. J. Pharm. 2015;495:374\u2013384. doi: 10.1016/j.ijpharm.2015.09.011.", "ArticleIdList": ["10.1016/j.ijpharm.2015.09.011", "26364711"]}, {"Citation": "Cheema M., Palin K.J., Davis S.S. Lipid vehicles for intestinal lymphatic drug absorption. J. Pharm. Pharmacol. 1987;39:55\u201356. doi: 10.1111/j.2042-7158.1987.tb07164.x.", "ArticleIdList": ["10.1111/j.2042-7158.1987.tb07164.x", "2880987"]}, {"Citation": "Chen Y., Lu Y., Chen J., Lai J., Sun J., Hu F., Wu W. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int. J. Pharm. 2009;376:153\u2013160. doi: 10.1016/j.ijpharm.2009.04.022.", "ArticleIdList": ["10.1016/j.ijpharm.2009.04.022", "19394416"]}, {"Citation": "Cheng L., Wong H. Food effects on oral drug absorption: application of physiologically-based pharmacokinetic modeling as a predictive tool. Pharmaceutics. 2020;12:672. doi: 10.3390/pharmaceutics12070672.", "ArticleIdList": ["10.3390/pharmaceutics12070672", "PMC7408216", "32708881"]}, {"Citation": "Chidambaram M., Manavalan R., Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 2011;14", "ArticleIdList": ["21501554"]}, {"Citation": "Cho Y.-D., Park Y.-J. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate. Arch. Pharm. Res. 2013;37:193\u2013203. doi: 10.1007/s12272-013-0169-4.", "ArticleIdList": ["10.1007/s12272-013-0169-4", "23754165"]}, {"Citation": "Christie W.W. Pergamon Press; 1987. High-performance liquid chromatography and lipids."}, {"Citation": "Crison, J.R., Amidon, G.L, inventors; Port Systems LLC, assignee, 1999. Method and formulation for increasing the bioavailability of poorly watersoluble drugs. United States Patent US 5993858A. 1999 Nov 30."}, {"Citation": "Crounse R.G. Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption11from the Department of Dermatology, University of Miami Medical School, Miami, Florida. J. Invest. Dermatol. 1961;37:529\u2013533. doi: 10.1038/jid.1961.154.", "ArticleIdList": ["10.1038/jid.1961.154", "13882411"]}, {"Citation": "Cuin\u00e9 J.F., McEvoy C.L., Charman W.N., Pouton C.W., Edwards G.A., Benameur H., Porter C.J.H. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of Lipidic self-emulsifying formulations to dogs. J. Pharm. Sci. 2008;97:995\u20131012. doi: 10.1002/jps.21246.", "ArticleIdList": ["10.1002/jps.21246", "18064698"]}, {"Citation": "Cunningham K.M., Baker R.J., Horowitz M., Maddox A.F., Edelbroek M.AL., Chatterton B.E. Use of technetium-99m (V) thiocyanate to measure gastric emptying of fat. J. Nucl. Med. 1991;32(5):878\u2013881.", "ArticleIdList": ["2023000"]}, {"Citation": "Custodio J.M., Wu C.-Y., Benet L.Z. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv. Drug Deliv. Rev. 2008;60:717\u2013733. doi: 10.1016/j.addr.2007.08.043.", "ArticleIdList": ["10.1016/j.addr.2007.08.043", "PMC2292816", "18199522"]}, {"Citation": "Czogalla A. Oral cyclosporine a - the current picture of its liposomal and other delivery systems. Cell. Mol. Biol. Lett. 2009;14 doi: 10.2478/s11658-008-0041-6.", "ArticleIdList": ["10.2478/s11658-008-0041-6", "PMC6275704", "19005620"]}, {"Citation": "Derosa F., Guild B.C., Heartlein M.W. Lipid-derived neutral nanoparticles. AU Patent AU2022204907A1. 2022 https://patents.google.com/patent/AU2022204907A1/en?oq"}, {"Citation": "Desai N.S., Nagarsenker M.S. Design and evaluation of self-nanoemulsifying pellets of repaglinide. AAPS PharmSciTech. 2013;14:994\u20131003. doi: 10.1208/s12249-013-9990-9.", "ArticleIdList": ["10.1208/s12249-013-9990-9", "PMC3755138", "23775389"]}, {"Citation": "Dong X., Mattingly C.A., Tseng M.T., Cho M.J., Liu Y., Adams V.R., Mumper R.J. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res. 2009;69:3918\u20133926. doi: 10.1158/0008-5472.can-08-2747.", "ArticleIdList": ["10.1158/0008-5472.can-08-2747", "PMC2758164", "19383919"]}, {"Citation": "Dressman J.B., Amidon G.L., Reppas C., Shah V.P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 1998;15:11\u201322.", "ArticleIdList": ["9487541"]}, {"Citation": "Embleton J.K., Pouton C.W. Structure and function of gastro-intestinal lipases. Adv. Drug Deliv. Rev. 1997;25:15\u201332. doi: 10.1016/s0169-409x(96)00488-7.", "ArticleIdList": ["10.1016/s0169-409x(96)00488-7"]}, {"Citation": "Fatouros D.G., Bergenstahl B., Mullertz A. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur. J. Pharm. Sci. 2007;31:85\u201394. doi: 10.1016/j.ejps.2007.02.009.", "ArticleIdList": ["10.1016/j.ejps.2007.02.009", "17418543"]}, {"Citation": "Faustino P. Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics. 2020;12:29. doi: 10.3390/pharmaceutics12010029.", "ArticleIdList": ["10.3390/pharmaceutics12010029", "PMC7023008", "31906268"]}, {"Citation": "Feinle C., Rades T., Otto B., Fried M. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology. 2001;120:1100\u20131107. doi: 10.1053/gast.2001.23232.", "ArticleIdList": ["10.1053/gast.2001.23232", "11266374"]}, {"Citation": "Fleisher D., Li C., Zhou Y., Pao L., Karim A. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin. Pharmacokinet. 1999;36:233\u2013254. doi: 10.2165/00003088-199936030-00004.", "ArticleIdList": ["10.2165/00003088-199936030-00004", "10223170"]}, {"Citation": "Fried M., Mayer E.A., Jansen J.B.M.J., Lamers C.B.H.W., Taylor I.L., Bloom S.R., Meyer J.H. Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. Gastroenterology. 1988;95:1344\u20131350. doi: 10.1016/0016-5085(88)90371-x.", "ArticleIdList": ["10.1016/0016-5085(88)90371-x", "3169498"]}, {"Citation": "Froehlich F., Gonvers J.J., Fried M. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in man. Dig. Dis. Sci. 1995;40:529\u2013533. doi: 10.1007/bf02064362.", "ArticleIdList": ["10.1007/bf02064362", "7895538"]}, {"Citation": "Furuhashi M., Saitoh S., Shimamoto K., Miura T. Fatty acid-binding protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Medicine Insights Cardiol. 2014;8s3 doi: 10.4137/cmc.s17067.", "ArticleIdList": ["10.4137/cmc.s17067", "PMC4315049", "25674026"]}, {"Citation": "Gao, P., Morozowich, W., Shenoy, N., inventors; Pharmacia & Upjohn CompanySugen, Inc., assignee, 2002. Self-emulsifying drug delivery systems for extremely waterinsoluble, lipophilic drugs. PCT. WO Application WO 2002007712A2. 2002 Jan 31."}, {"Citation": "Garzon-Aburbeh A., Poupaert J.H., Claesen M., Dumont P., Atassi G. Cheminform abstract: 1,3-DIPALMITOYLGLYCEROL ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent. Chemischer Informationsdienst. 1983;14 doi: 10.1002/chin.198350127.", "ArticleIdList": ["10.1002/chin.198350127", "6876088"]}, {"Citation": "Geng D., Li Y., Wang C., Ren B., Wang H., Wu C., Zhang Y., Zhao L., Zhao L. Optimization, and in\u00a0vitro and in\u00a0vivo evaluation of etomidate intravenous lipid emulsion. Drug Deliv. 2021;28:873\u2013883. doi: 10.1080/10717544.2021.1917729.", "ArticleIdList": ["10.1080/10717544.2021.1917729", "PMC8118403", "33960250"]}, {"Citation": "Gershanik T. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 2000;50:179\u2013188. doi: 10.1016/s0939-6411(00)00089-8.", "ArticleIdList": ["10.1016/s0939-6411(00)00089-8", "10840200"]}, {"Citation": "Gershkovich P., Hoffman A. Effect of a high-fat meal on absorption and disposition of lipophilic compounds: The importance of degree of association with triglyceride-rich lipoproteins. Eur. J. Pharm. Sci. 2007;32:24\u201332. doi: 10.1016/j.ejps.2007.05.109.", "ArticleIdList": ["10.1016/j.ejps.2007.05.109", "17604610"]}, {"Citation": "Gokhale, R., Griffin, M.J., Truelove, J.E., Stolzenbach, J.C., Karim, A., Roy, A.K., inventors; GD Searle LLC, assignee, 2007. Self-emulsifying drug delivery system. United States Patent US 7226932B2. 2007 June 5."}, {"Citation": "Greenberger N.J., Rodgers J.B., Isselbacher K.J. Absorption of medium and long chain triglycerides: Factors influencing their hydrolysis and transport. J. Clin. Investig. 1966;45:217\u2013227. doi: 10.1172/jci105334.", "ArticleIdList": ["10.1172/jci105334", "PMC292686", "5901507"]}, {"Citation": "Gursoy, R.N., \u00c7evic, \u00d6., inventors, 2014. Lipid-based nanocarrier systems for using cancer treatment. WO Application WO 2013100869A3. 2014 Oct 24."}, {"Citation": "Hall J.B., Dobrovolskaia M.A., Patri A.K., McNeil S.E. Characterization of nanoparticles for therapeutics. Nanomedicine. 2007;2:789\u2013803. doi: 10.2217/17435889.2.6.789.", "ArticleIdList": ["10.2217/17435889.2.6.789", "18095846"]}, {"Citation": "Harrison E.H. Mechanisms of digestion and absorption of dietary vitamin A. Annu. Rev. Nutr. 2005;25:87\u2013103.", "ArticleIdList": ["16011460"]}, {"Citation": "Hernell O., Staggers J.E., Carey M.C. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 1990;29:2041\u20132056. doi: 10.1021/bi00460a012.", "ArticleIdList": ["10.1021/bi00460a012", "2328238"]}, {"Citation": "Hinsberger A., Sandhu B.K. Digestion and absorption. Curr. Paediatr. 2004;14(7):605\u2013611."}, {"Citation": "Hoffman A., Dahan A. Enhanced gastrointestinal absorption of lipophilic drugs. Enhancement Drug Deliv. 2006 doi: 10.1201/9781420004816.ch6.", "ArticleIdList": ["10.1201/9781420004816.ch6"]}, {"Citation": "Holmberg, C., Siekmann, B., inventors; Nicox, S.A., assignee, 2010. Self-emulsifying drug delivery system. United States Patent US 7736666B2. 2010 June 15."}, {"Citation": "Hosny K.M. Development of saquinavir mesylate nanoemulsion-loaded transdermal films: two-step optimization of permeation parameters, characterization, and ex vivo and in vivo evaluation. Int. J. Nanomed. 2019;14:8589\u20138601. doi: 10.2147/ijn.s230747.", "ArticleIdList": ["10.2147/ijn.s230747", "PMC6830379", "31802871"]}, {"Citation": "Humberstone A.J., Porter C.J.H., Charman W.N. A physicochemical basis for the effect of food on the absolute oral bioavailability of Halofantrine. J. Pharm. Sci. 1996;85:525\u2013529. doi: 10.1021/js950472p.", "ArticleIdList": ["10.1021/js950472p", "8742945"]}, {"Citation": "Hustvedt, S.O., Berge, G., Olesen, P.H., M\u00fcllertz, A., inventors, 2014. Pronova BioPharma Norge AS, assignee.Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin. United States Patent US 20140017308A1. 2014 Jan 16."}, {"Citation": "Igor LegenJanez KercPolona Jurkovic, Self-microemulsifying drug delivery systems\u201d, CA Patent CA2674128A1, 2007 july 3rd. https://patents.google.com/patent/CA2674128A1/en?q."}, {"Citation": "Ichihashi T., Kinoshita H., Takagishi Y., Yamada H. Effect of oily vehicles on absorption of Mepitiostane by the lymphatic system in rats. J. Pharm. Pharmacol. 1992;44:560\u2013564. doi: 10.1111/j.2042-7158.1992.tb05464.x.", "ArticleIdList": ["10.1111/j.2042-7158.1992.tb05464.x", "1357134"]}, {"Citation": "Jaiswal M., Dudhe R., Sharma P.K. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2014;5:123\u2013127. doi: 10.1007/s13205-014-0214-0.", "ArticleIdList": ["10.1007/s13205-014-0214-0", "PMC4362737", "28324579"]}, {"Citation": "Jannin V., Musakhanian J., Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv. Drug Deliv. Rev. 2008;60:734\u2013746. doi: 10.1016/j.addr.2007.09.006.", "ArticleIdList": ["10.1016/j.addr.2007.09.006", "18045728"]}, {"Citation": "Jesorka A., Orwar O. Liposomes: Technologies and analytical applications. Annu. Rev. Anal. Chem. 2008;1:801\u2013832. doi: 10.1146/annurev.anchem.1.031207.112747.", "ArticleIdList": ["10.1146/annurev.anchem.1.031207.112747", "20636098"]}, {"Citation": "Kalantzi L., Goumas K., Kalioras V., Abrahamsson B., Dressman J.B., Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm. Res. 2006;23:165\u2013176. doi: 10.1007/s11095-005-8476-1.", "ArticleIdList": ["10.1007/s11095-005-8476-1", "16308672"]}, {"Citation": "Kalepu S., Manthina M., Padavala V. Oral lipid-based drug delivery systems \u2013 an overview. Acta Pharm. Sin. B. 2013;3:361\u2013372. doi: 10.1016/j.apsb.2013.10.001.", "ArticleIdList": ["10.1016/j.apsb.2013.10.001"]}, {"Citation": "Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee H.B., Cho S.H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in Beagle Dogs. Int. J. Pharm. 2004;274:65\u201373. doi: 10.1016/j.ijpharm.2003.12.028.", "ArticleIdList": ["10.1016/j.ijpharm.2003.12.028", "15072783"]}, {"Citation": "Karasulu, H.Y., Apaydin, S., Gundogdu, E., Yildirim, S.L., Turk, U.O., Karasulu, E., Yilmaz, C., Turgay, T., inventors; T.C. Ege Universitesi, assignee, 2015. Self-micro/nanoemulsifying drug carrying system for oral use of rosuvastatin. PCT. WO Application WO 2015142307A1. 2015 Sept 24."}, {"Citation": "Keohane K., Rosa M., Coulter I.S., Griffin B.T. Enhanced colonic delivery of ciclosporin a self-emulsifying drug delivery system encapsulated in Coated Minispheres. Drug Dev. Ind. Pharm. 2015;42:245\u2013253. doi: 10.3109/03639045.2015.1044905.", "ArticleIdList": ["10.3109/03639045.2015.1044905", "26083078"]}, {"Citation": "Kessel A., Toubi E. Chronic HCV-related autoimmunity: A consequence of viral persistence and lymphotropism. Curr. Med. Chem. 2007;14:547\u2013554. doi: 10.2174/092986707780059652.", "ArticleIdList": ["10.2174/092986707780059652", "17346146"]}, {"Citation": "Khan, M.A., Nazzar, S., inventors; Jarrow Formulas Inc., assignee, 2014. Eutectic-based self-nanoemulsified drug delivery system. United States Patent US 8790723B2. 2014 July 29."}, {"Citation": "Kohli K., Chopra S., Dhar D., Arora S., Khar R.K. Self-emulsifying drug delivery systems: An approach to enhance oral bioavailability. Drug Discov. Today. 2010;15:958\u2013965. doi: 10.1016/j.drudis.2010.08.007.", "ArticleIdList": ["10.1016/j.drudis.2010.08.007", "20727418"]}, {"Citation": "Kohli, Kanchan, Sunny Chopra, Saurabh Arora, Roop K. Khar, and Kolappa K. Pillai. \u201cSelf emulsifying drug delivery system for a curcuminoid based composition.\u201d U.S. Patent 8,835,509, issued September 16, 2014."}, {"Citation": "Kommuru T.R., Gurley B., Khan M.A., Reddy I.K. Self-Emulsifying Drug Delivery Systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int. J. Pharm. 2001;212:233\u2013246. doi: 10.1016/s0378-5173(00)00614-1.", "ArticleIdList": ["10.1016/s0378-5173(00)00614-1", "11165081"]}, {"Citation": "Kossena G.A., Boyd B.J., Porter C.J.H., Charman W.N. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J. Pharm. Sci. 2003;92:634\u2013648. doi: 10.1002/jps.10329.", "ArticleIdList": ["10.1002/jps.10329", "12587125"]}, {"Citation": "Kossena G.A., Charman W.N., Wilson C.G., O\u2019Mahony B., Lindsay B., Hempenstall J.M., Davison C.L., Crowley P.J., Porter C.J. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharm. Res. 2007;24:2084\u20132096. doi: 10.1007/s11095-007-9363-8.", "ArticleIdList": ["10.1007/s11095-007-9363-8", "17657595"]}, {"Citation": "Kovarik J.M., Mueller E.A., Kutz K., Van Bree J.B., Tetzloff W. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J. Pharm. Sci. 1994;83:444\u2013446. doi: 10.1002/jps.2600830336.", "ArticleIdList": ["10.1002/jps.2600830336", "8207699"]}, {"Citation": "Kozlov M.M., Helfrich W. Effects of a cosurfactant on the stretching and bending elasticities of a surfactant monolayer. Langmuir. 1992;8:2792\u20132797. doi: 10.1021/la00047a035.", "ArticleIdList": ["10.1021/la00047a035"]}, {"Citation": "Lai Z.W., Yan Y., Caruso F., Nice E.C. Emerging techniques in proteomics for probing nano\u2013bio interactions. ACS Nano. 2012;6:10438\u201310448. doi: 10.1021/nn3052499.", "ArticleIdList": ["10.1021/nn3052499", "23214939"]}, {"Citation": "Lalanne M., Paci A., Andrieux K., Dereuddre-Bosquet N., Clayette P., Deroussent A., R\u00e9 M., Vassal G., Couvreur P., Desma\u00eble D. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV. Bioorg. Med. Chem. Lett. 2007;17:2237\u20132240. doi: 10.1016/j.bmcl.2007.01.062.", "ArticleIdList": ["10.1016/j.bmcl.2007.01.062", "17276686"]}, {"Citation": "Lambert, G., Razafindratsita, A., Garrigue, J.S., Yang, S., Gursoy, N., Benita, S., inventors; Novagali SA, Yissum Research Development Co of Hebrew University, assignees, 2005. Self-emulsifying drug delivery systems for poorly soluble drugs. United States Patent US 20050232952A1. 2005 Oct 20."}, {"Citation": "Leak L.V. The structure of lymphatic capillaries in lymph formation. Federation Proc. 1976;35(8):1863\u20131871.", "ArticleIdList": ["1269772"]}, {"Citation": "Lee D.H., Yeom D.W., Song Y.S., Cho H.R., Choi Y.S., Kang M.J., Choi Y.W. Improved oral absorption of dutasteride via Soluplus \u00ae -based supersaturable self-emulsifying drug delivery system (S-SEDDS) Int. J. Pharm. 2015;478:341\u2013347. doi: 10.1016/j.ijpharm.2014.11.060.", "ArticleIdList": ["10.1016/j.ijpharm.2014.11.060", "25437113"]}, {"Citation": "Legen, I., Peternel, L., Novak, S.M., Homar, M., Rozman, P.T., Klancar, U., inventors; Sandoz Ag, assignee, 2013. Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate. PCT. WO Application WO 2014009434A1. 2014 Jan 16."}, {"Citation": "Li C., David Fleisher L., Li J.R., Schwier S.A., Sweetana V., Vasudevan L.L., Zornes L.-H., Zhou S.Y., Stratford R.E. Regional-dependent intestinal absorption and meal composition effects on systemic availability of LY303366, a lipopeptide antifungal agent, in dogs. J. Pharm. Sci. 2001;90(1):47\u201357.", "ArticleIdList": ["11064378"]}, {"Citation": "Lin P.-C., Lin S., Wang P.C., Sridhar R. Techniques for physicochemical characterization of Nanomaterials. Biotechnol. Adv. 2014;32:711\u2013726. doi: 10.1016/j.biotechadv.2013.11.006.", "ArticleIdList": ["10.1016/j.biotechadv.2013.11.006", "PMC4024087", "24252561"]}, {"Citation": "Lin, J., inventor, 2012. Catalent Australia Pty Ltd, assignee. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10. United States Patent US 20060275358A1. 2012 Aug 28."}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2012;64:4\u201317. doi: 10.1016/j.addr.2012.09.019.", "ArticleIdList": ["10.1016/j.addr.2012.09.019", "11259830"]}, {"Citation": "Ljusberg-Wahren H., Seier Nielsen F., Brog\u00e5rd M., Troedsson E., M\u00fcllertz A. Enzymatic characterization of lipid-based drug delivery systems. Int. J. Pharm. 2005;298:328\u2013332. doi: 10.1016/j.ijpharm.2005.02.038.", "ArticleIdList": ["10.1016/j.ijpharm.2005.02.038", "15979260"]}, {"Citation": "Malhotra, A.G., Madhukar, S.P., inventors; Cipla LimitedTurner, C, assignees, 2015. Pharmaceutical compositions comprising efavirenz. WO Application WO 2015059466A1. 2015 April 30."}, {"Citation": "Manoharan, M., Rajeev, K.G., Butler, D., Jayaprakash, N.K., Jayaraman, M., Eltepu, L., 2012. Novel lipids and compositions for the delivery of therapeutics. U.S. Patent Application 13/211,150, filed April 19, 2012."}, {"Citation": "Martinez M. Applying the biopharmaceutics classification system to Veterinary Pharmaceutical Products Part II. physiological considerations. Adv. Drug Deliv. Rev. 2002;54:825\u2013850. doi: 10.1016/s0169-409x(02)00071-6.", "ArticleIdList": ["10.1016/s0169-409x(02)00071-6", "12363433"]}, {"Citation": "Mu H., Porsgaard T. The metabolism of structured triacylglycerols. Prog. Lipid Res. 2005;44:430\u2013448. doi: 10.1016/j.plipres.2005.09.002.", "ArticleIdList": ["10.1016/j.plipres.2005.09.002", "16269186"]}, {"Citation": "Muller R. Cyclosporine-loaded solid lipid nanoparticles (SLN\u00ae): Drug\u2013lipid physicochemical interactions and characterization of drug incorporation. Eur. J. Pharm. Biopharm. 2008;68:535\u2013544. doi: 10.1016/j.ejpb.2007.07.006.", "ArticleIdList": ["10.1016/j.ejpb.2007.07.006", "17804210"]}, {"Citation": "M\u00fcller R.H., R\u00fchl D., Runge S., Schulze-Forster K., Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 1997;14:458\u2013462.", "ArticleIdList": ["9144731"]}, {"Citation": "Narang J., Khan S., Baboota S., Ali J., Khan S., Narang R. Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs. Int. J. Pharm. Investigation. 2015;5:182. doi: 10.4103/2230-973x.167661.", "ArticleIdList": ["10.4103/2230-973x.167661", "PMC4674999", "26682188"]}, {"Citation": "Natesan V., Kim S.-J. Lipid metabolism, disorders and therapeutic drugs - review. Biomol. Ther. 2021;29:596\u2013604. doi: 10.4062/biomolther.2021.122.", "ArticleIdList": ["10.4062/biomolther.2021.122", "PMC8551734", "34697272"]}, {"Citation": "Nicolaides E., Symillides M., Dressman J.B., Reppas C. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 2001;18:380\u2013388.", "ArticleIdList": ["11442280"]}, {"Citation": "O\u2019Driscoll C.M., Griffin B.T. Biopharmaceutical challenges associated with drugs with low aqueous solubility\u2014the potential impact of lipid-based formulations. Adv. Drug Deliv. Rev. 2008;60:617\u2013624. doi: 10.1016/j.addr.2007.10.012.", "ArticleIdList": ["10.1016/j.addr.2007.10.012", "18155800"]}, {"Citation": "Ollivon M., Eidelman O., Blumenthal R., Walter A. Micelle-vesicle transition of egg phosphatidylcholine and octylglucoside. Biochemistry. 1988;27:1695\u20131703. doi: 10.1021/bi00405a047.", "ArticleIdList": ["10.1021/bi00405a047", "3365419"]}, {"Citation": "Pandey V., Kohli S. Lipids and surfactants: the inside story of lipid-based drug delivery systems. Critical ReviewsTM Therapeutic Drug Carrier Syst. 2018;35:99\u2013155. doi: 10.1615/critrevtherdrugcarriersyst.2018016710.", "ArticleIdList": ["10.1615/critrevtherdrugcarriersyst.2018016710", "29717664"]}, {"Citation": "Pantaleo G., Graziosi C., Fauci A.S. The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS. 1993;7 doi: 10.1097/00002030-199301001-00003.", "ArticleIdList": ["10.1097/00002030-199301001-00003", "8363784"]}, {"Citation": "Pantaleo G., Graziosi C., Demarest J.F., Cohen O.J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A.S. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol. Rev. 1994;140:105\u2013130. doi: 10.1111/j.1600-065x.1994.tb00867.x.", "ArticleIdList": ["10.1111/j.1600-065x.1994.tb00867.x", "7821924"]}, {"Citation": "Paternostre M.T., Roux M., Rigaud J.L. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 1. solubilization of large unilamellar liposomes (prepared by reverse-phase evaporation) by Triton X-100, octyl glucoside, and sodium cholate. Biochemistry. 1988;27:2668\u20132677. doi: 10.1021/bi00408a006.", "ArticleIdList": ["10.1021/bi00408a006", "2840945"]}, {"Citation": "Porter C.J.H., Charman W.N. In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 2001;50 doi: 10.1016/s0169-409x(01)00182-x.", "ArticleIdList": ["10.1016/s0169-409x(01)00182-x", "11576699"]}, {"Citation": "Porter C.J.H., Pouton C.W., Cuine J.F., Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008;60:673\u2013691. doi: 10.1016/j.addr.2007.10.014.", "ArticleIdList": ["10.1016/j.addr.2007.10.014", "18155801"]}, {"Citation": "Pouton C.W. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems. Eur. J. Pharm. Sci. 2000;11 doi: 10.1016/s0928-0987(00)00167-6.", "ArticleIdList": ["10.1016/s0928-0987(00)00167-6", "11033431"]}, {"Citation": "Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006;29:278\u2013287. doi: 10.1016/j.ejps.2006.04.016.", "ArticleIdList": ["10.1016/j.ejps.2006.04.016", "16815001"]}, {"Citation": "Pouton C.W., Porter C.J.H. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 2008;60:625\u2013637. doi: 10.1016/j.addr.2007.10.010.", "ArticleIdList": ["10.1016/j.addr.2007.10.010", "18068260"]}, {"Citation": "Ptachcinski R.J., Venkataramanan R., Burckart G.J. Clinical pharmacokinetics of cyclosporin. Clin. Pharmacokinet. 1986;11:107\u2013132. doi: 10.2165/00003088-198611020-00002.", "ArticleIdList": ["10.2165/00003088-198611020-00002", "3514043"]}, {"Citation": "Qureshi M.J., Mallikarjun C., Kian W.G. Enhancement of solubility and therapeutic potential of poorly soluble lovastatin by SMEDDS formulation adsorbed on directly compressed spray dried magnesium aluminometasilicate liquid loadable tablets: a study in diet induced hyperlipidemic rabbits. Asian J. Pharm. Sci. 2015;10:40\u201356. doi: 10.1016/j.ajps.2014.08.003.", "ArticleIdList": ["10.1016/j.ajps.2014.08.003"]}, {"Citation": "Raybould H.E., Meyer J.H., Tabrizi Y., Liddle R.A., Tso P. Inhibition of gastric emptying in response to intestinal lipid is dependent on Chylomicron Formation. Am. J. Physiol.-Regulatory, Integrative Comparative Physiol. 1998;274 doi: 10.1152/ajpregu.1998.274.6.r1834.", "ArticleIdList": ["10.1152/ajpregu.1998.274.6.r1834", "9841489"]}, {"Citation": "Rodr\u00edguez S.A., Qiu F., Mulcey M., Weigandt K., Tamblyn T. Monitoring the chemical and physical stability for tromethamine excipient in a lipid based formulation by HPLC coupled with ELSD. J. Pharm. Biomed. Anal. 2015;115:245\u2013253. doi: 10.1016/j.jpba.2015.07.010.", "ArticleIdList": ["10.1016/j.jpba.2015.07.010", "26254033"]}, {"Citation": "Schmidt L.E., Dalhoff K. Food-drug interactions. Drugs. 2002;62:1481\u20131502.", "ArticleIdList": ["12093316"]}, {"Citation": "Schwarz C., Mehnert W., Lucks J.S., M\u00fcller R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release. 1994;30(1):83\u201396."}, {"Citation": "Shah, V.P., Amidon, G.L., 2014. G.L. Amidon, H. Lennernas, V.P. Shah, J.R. Crison, 2014. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413\u2013420, 1995\u2014backstory of BCS. The AAPS Journal 16, 894\u2013898. 10.1208/s12248-014-9620-9.", "ArticleIdList": ["PMC4147045", "24961917"]}, {"Citation": "Shah N.H., Carvajal M.T., Patel C.I., Infeld M.H., Malick A.W. Self-Emulsifying Drug Delivery Systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 1994;106:15\u201323. doi: 10.1016/0378-5173(94)90271-2.", "ArticleIdList": ["10.1016/0378-5173(94)90271-2"]}, {"Citation": "Sharipova A., Aidarova S., Mutaliyeva B., Babayev A., Issakhov M., Issayeva A., Madybekova G., Grigoriev D., Miller R. The use of polymer and surfactants for the microencapsulation and emulsion stabilization. Colloids and Interfaces. 2017;1:3. doi: 10.3390/colloids1010003.", "ArticleIdList": ["10.3390/colloids1010003"]}, {"Citation": "Shrestha H., Bala R., Arora S. Lipid-based drug delivery systems. J. Pharm. 2014;2014", "ArticleIdList": ["PMC4590796", "26556202"]}, {"Citation": "Silva A.C., Moreira J.N., Lobo J.M. Editorial\u2014current insights on lipid-based Nanosystems. Pharmaceuticals. 2022;15:1267. doi: 10.3390/ph15101267.", "ArticleIdList": ["10.3390/ph15101267", "PMC9611633", "36297379"]}, {"Citation": "Spiegel M., Schneider K., Weber F., Weidmann M., Hufert F.T. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J. Gen. Virol. 2006;87:1953\u20131960. doi: 10.1099/vir.0.81624-0.", "ArticleIdList": ["10.1099/vir.0.81624-0", "16760397"]}, {"Citation": "Stella V.J. Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations. Pharm. Res. 2013;30:3018\u20133028. doi: 10.1007/s11095-013-1051-2.", "ArticleIdList": ["10.1007/s11095-013-1051-2", "23636838"]}, {"Citation": "Stone B.G., Ansel H.J., Peterson F.J., Gebhard R.L. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology. 1992;15:795\u2013798. doi: 10.1002/hep.1840150508.", "ArticleIdList": ["10.1002/hep.1840150508", "1568719"]}, {"Citation": "Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Investig. 1988;82:2001\u20132010. doi: 10.1172/jci113820.", "ArticleIdList": ["10.1172/jci113820", "PMC442782", "3198762"]}, {"Citation": "Thomson A.B. Intestinal aspects of lipid absorption. Nutrition Today. 1989;24:16\u201320. doi: 10.1097/00017285-198907000-00004.", "ArticleIdList": ["10.1097/00017285-198907000-00004"]}, {"Citation": "Tokumura T., Tsushima Y., Tatsuishi K., Kayano M., Machida Y., Nagai T. Enhancement of the oral bioavailability of cinnarizine in oleic acid in Beagle Dogs. J. Pharm. Sci. 1987;76:286\u2013288. doi: 10.1002/jps.2600760404.", "ArticleIdList": ["10.1002/jps.2600760404", "3598885"]}, {"Citation": "Trevaskis N.L., Porter C.J.H., Charman W.N. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. Drug Metab. Dispos. 2006;34:729\u2013733. doi: 10.1124/dmd.105.008102.", "ArticleIdList": ["10.1124/dmd.105.008102", "16467133"]}, {"Citation": "Trevaskis N.L., Charman W.N., Porter C.J.H. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv. Drug Deliv. Rev. 2008;60:702\u2013716. doi: 10.1016/j.addr.2007.09.007.", "ArticleIdList": ["10.1016/j.addr.2007.09.007", "PMC7103284", "18155316"]}, {"Citation": "Ugazio E., Cavalli R., Gasco M.R. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) Int. J. Pharm. 2002;241:341\u2013344. doi: 10.1016/s0378-5173(02)00268-5.", "ArticleIdList": ["10.1016/s0378-5173(02)00268-5", "12100861"]}, {"Citation": "Umeda M., Marusawa H., Seno H., Katsurada A., Nabeshima M., Egawa H., Uemoto S., Inomata Y., Tanaka K., Chiba T. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J. Hepatol. 2005;42:806\u2013812. doi: 10.1016/j.jhep.2005.01.016.", "ArticleIdList": ["10.1016/j.jhep.2005.01.016", "15885350"]}, {"Citation": "Von Messling V., Svitek N., Cattaneo R. Receptor (slam [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J. Virol. 2006;80:6084\u20136092. doi: 10.1128/jvi.00357-06.", "ArticleIdList": ["10.1128/jvi.00357-06", "PMC1472607", "16731947"]}, {"Citation": "Voorspoels, J.F., inventor, 2007. Self-microemulsifying drug delivery systems of a HIV protease inhibitor. United States Patent US 20070104740A1. 2007 May 10."}, {"Citation": "Wacher V.J., Wu C.-Y., Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 1995;13:129\u2013134. doi: 10.1002/mc.2940130302.", "ArticleIdList": ["10.1002/mc.2940130302", "7619215"]}, {"Citation": "Wacher V.J., Salphati L., Benet L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev. 1996;20:99\u2013112. doi: 10.1016/0169-409x(95)00127-s.", "ArticleIdList": ["10.1016/0169-409x(95)00127-s", "11259835"]}, {"Citation": "Wagner D., Spahn-Langguth H., Hanafy A., Koggel A., Langguth P. Intestinal drug efflux: Formulation and food effects. Adv. Drug Deliv. Rev. 2001;50 doi: 10.1016/s0169-409x(01)00183-1.", "ArticleIdList": ["10.1016/s0169-409x(01)00183-1", "11576693"]}, {"Citation": "Wasan K.M. The biological functions of lipid excipients and the implications for Pharmaceutical Products Development. J. Pharm. Sci. 2009;98:379\u2013382. doi: 10.1002/jps.21435.", "ArticleIdList": ["10.1002/jps.21435", "18484625"]}, {"Citation": "Weng T., Qi J., Lu Y., Wang K., Tian Z., Hu K., Yin Z., Wu W. The role of lipid-based nano delivery systems on oral bioavailability enhancement of Fenofibrate, a BCS II drug: comparison with fast-release formulations. J. Nanobiotechnol. 2014;12 doi: 10.1186/s12951-014-0039-3.", "ArticleIdList": ["10.1186/s12951-014-0039-3", "PMC4180958", "25248304"]}, {"Citation": "Williams D.B., Carter C.B. The transmission electron microscope. Transmission Electron Microscopy. 2009;3\u201322 doi: 10.1007/978-0-387-76501-3_1.", "ArticleIdList": ["10.1007/978-0-387-76501-3_1"]}, {"Citation": "Woodley J.F. Liposomes for oral administration of drugs. Crit. Rev. Ther. Drug Carrier Syst. 1985;2(1):1\u201318.", "ArticleIdList": ["3913528"]}, {"Citation": "Zhang X., Xu L., Liang W., Yu J., Wu W., Huang Y. In vivo evaluations of lipid-based drug delivery systems: opportunities and challenges. Pharmaceutics. 2021;13(6):790. doi: 10.3390/pharmaceutics13060790.", "ArticleIdList": ["10.3390/pharmaceutics13060790", "PMC8228148", "34070646"]}, {"Citation": "Zuther J.E., Norton S. Thieme; New York: 2018. Lymphedema management: The Comprehensive Guide for Practitioners."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "7"}, {"Year": "2023", "Month": "11", "Day": "9"}, {"Year": "2023", "Month": "12", "Day": "6", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "6", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "12", "Day": "6", "Hour": "4", "Minute": "9"}, {"Year": "2023", "Month": "11", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38053738", "PMC10694332", "10.1016/j.jsps.2023.101870", "S1319-0164(23)00365-1"]}}], "PubmedBookArticle": []}